Drug Combination Improves Outcome For Advanced Non-small Cell Lung Cancer
Saturday, May 30, 2009 - 17:28
in Health & Medicine
A new study found that the combination of two drugs delays disease progression for patients with advanced non-small cell lung cancer. Results from the Phase III "ATLAS" trial have just been presented.
Read the whole article on Science Daily
More from Science Daily
Related
- Study shows drug combination improves outcome for advanced non-small cell lung cancerSat, 30 May 2009, 11:29:37 EDT
- Vandetanib shows clinical benefit when combined with docetaxel for lung cancerMon, 1 Jun 2009, 9:44:28 EDT
- Advanced lung cancer patients see improved, progression-free survivalThu, 13 Nov 2008, 10:51:04 EST
- Novel 4-drug combination proves safe for lung cancer treatmentThu, 13 Nov 2008, 10:30:54 EST
- Chemotherapy plus targeted therapies shows improved survival in advance-stage lung cancer patientsThu, 13 Nov 2008, 10:51:01 EST